WASHINGTON -- The head of the U.S. effort to produce a coronavirus vaccine says the first immunizations could happen on Dec. 12.
A Food and Drug Administration advisory committee is set to meet Dec. 10 to discuss Pfizer Inc.’s request for an emergency use authorization for its developing COVID-19 vaccine.
Pfizer and its German partner BioNTech recently announced that the vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.
Dr. Moncef Slaoui, head of the Operation Warp Speed, the coronavirus vaccine program, says plans are to ship vaccines to states within 24 hours of expected FDA approval.
Slaoui told CNN he expects vaccinations would begin on the second day after approval, Dec. 12
COVID-19 Precautions
Most patients with COVID-19 have mild to moderate symptoms. However, in a small proportion of patients, COVID-19 can lead to more severe illness, including death, particularly among those who are older or those who have chronic medical conditions.
COVID-19 spreads primarily through respiratory droplets produced when an infected person coughs or sneezes.
Symptoms include fever, cough, and difficulty breathing. Symptoms appear within 14 days of being exposed to an infectious person.
Virginia health officials urged the following precautions:
- Wash your hands often with soap and water for at least 20 seconds.
- Use an alcohol-based hand sanitizer only if soap and water are not available.
- Avoid touching your eyes, nose, and mouth.Cover your mouth and nose with a tissue or your sleeve (not your hands) when coughing or sneezing.
- Clean and disinfect frequently touched objects and surfaces.
- Stay home when you are sick.
- Avoid contact with sick people.
- Avoid non-essential travel.